Peginterferon alfa2a - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe AUST R: 91836Active ingredients:
Peginterferon alfa2a
Dosage form:
Injection, solution
Sponsor:
Echo Therapeutics Pty Ltd
Phone:
1300848328
|
From
27 May 2025
to
30 Sep 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply. This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328.
|
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe AUST R: 91837Active ingredients:
Peginterferon alfa2a
Dosage form:
Injection, solution
Sponsor:
Echo Therapeutics Pty Ltd
Phone:
1300848328
|
From
13 May 2025
to
30 Sep 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply. This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328.
|